# Cryo-Cell International Inc. (CCEL)

Source: https://www.quantisnow.com/company/CCEL
Generated: 2026-11-12T16:04:20.187Z

- Ticker: CCEL
- Exchange: AMEX
- Sector: Health Care
- Industry: Misc Health and Biotechnology Services
- IPO year: 2022
- SEC CIK: 0000862692
- Website: cryo-cell.com

## About

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

## Latest CCEL news and filings

- 2026-10-28 21:00 UTC [SEC Form 8-K] [SEC Form 8-K filed by Cryo-Cell International Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-cryo-cell-international-inc-6761754)
- 2026-10-28 21:00 UTC [SEC Form 4] [SEC Form 4 filed by Cryo-Cell International Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-cryo-cell-international-inc-6761748)
- 2026-10-28 21:00 UTC [SEC Form 4] [SEC Form 4 filed by Cryo-Cell International Inc.](https://www.quantisnow.com/insight/sec-form-4-filed-by-cryo-cell-international-inc-6761744)
- 2026-10-13 21:00 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Cryo-Cell International Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-cryo-cell-international-inc-6745384)
- 2026-10-09 20:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Cryo-Cell International Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cryo-cell-international-inc-6743044)
- 2026-10-09 20:30 UTC [Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2026 Financial Results](https://www.quantisnow.com/insight/cord-blood-banking-leader-cryo-cell-reports-fiscal-third-quarter-2026-6743001)
- 2026-09-14 20:30 UTC [SEC Form 8-K] [SEC Form 8-K filed by Cryo-Cell International Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-cryo-cell-international-inc-6714652)
- 2026-08-07 20:39 UTC [SEC Form 4] [Chairman, Co-CEO Portnoy David acquired $799,995 worth of shares (600,191 units at $1.33) and disposed of $799,995 worth of shares (600,191 units at $1.33), decreasing direct ownership by 71% to 247,438 units (SEC Form 4)](https://www.quantisnow.com/insight/chairman-co-ceo-portnoy-david-acquired-799995-worth-of-shares-600191-6671937)
- 2026-07-15 20:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Cryo-Cell International Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cryo-cell-international-inc-6638440)
- 2026-07-15 20:30 UTC [Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial Results](https://www.quantisnow.com/insight/cord-blood-banking-leader-cryo-cell-reports-fiscal-second-quarter-2026-6638419)
- 2026-05-29 20:30 UTC [SEC Form 4] [VP Finance, CFO Taymans Jill M exercised 7,500 shares at a strike of $3.10, increasing direct ownership by 17% to 52,896 units (SEC Form 4)](https://www.quantisnow.com/insight/vp-finance-cfo-taymans-jill-m-exercised-7500-shares-at-6579483)
- 2026-05-08 20:00 UTC [SEC Form 8-K] [Cryo-Cell International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cryo-cell-international-inc-filed-sec-form-8-k-notice-of-delisting-6541876)
- 2026-05-08 20:00 UTC [Cryo-Cell Receives Acceptance of Compliance Plan From NYSE American](https://www.quantisnow.com/insight/cryo-cell-receives-acceptance-of-compliance-plan-from-nyse-american-6541853)
- 2026-04-28 20:00 UTC [Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks](https://www.quantisnow.com/insight/cryo-cell-international-receives-fact-re-accreditation-setting-the-longest-independently-validated-6518346)
- 2026-04-14 21:00 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Cryo-Cell International Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cryo-cell-international-inc-6499889)
- 2026-04-14 21:00 UTC [Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2026 Financial Results](https://www.quantisnow.com/insight/cord-blood-banking-leader-cryo-cell-reports-fiscal-first-quarter-2026-6499874)
- 2026-03-12 21:00 UTC [SEC Form 8-K] [Cryo-Cell International Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cryo-cell-international-inc-filed-sec-form-8-k-notice-of-delisting-6445220)
- 2026-03-12 21:00 UTC [Cryo-Cell Receives NYSE American Continued Listing Notice](https://www.quantisnow.com/insight/cryo-cell-receives-nyse-american-continued-listing-notice-6445200)
- 2026-02-27 22:01 UTC [SEC Form 10-K] [SEC Form 10-K filed by Cryo-Cell International Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-cryo-cell-international-inc-6419741)
- 2026-02-27 22:00 UTC [Earnings] [Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025](https://www.quantisnow.com/insight/cryo-cell-reports-financial-results-for-fiscal-year-ended-november-30-6419707)
- 2026-01-09 22:00 UTC [SEC Form 4] [SEC Form 4 filed by Chairman, Co-CEO Portnoy David](https://www.quantisnow.com/insight/sec-form-4-filed-by-chairman-co-ceo-portnoy-david-6344685)
- 2026-01-09 22:00 UTC [SEC Form 4] [SEC Form 4 filed by Co-CEO Portnoy Mark L.](https://www.quantisnow.com/insight/sec-form-4-filed-by-co-ceo-portnoy-mark-l-6344683)
- 2026-01-09 22:00 UTC [SEC Form 4] [SEC Form 4 filed by Chief Information Officer Mikulinsky Oleg](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-information-officer-mikulinsky-oleg-6344682)
- 2026-01-09 22:00 UTC [SEC Form 4] [SEC Form 4 filed by VP Finance, CFO Taymans Jill M](https://www.quantisnow.com/insight/sec-form-4-filed-by-vp-finance-cfo-taymans-jill-6344681)
- 2025-11-24 22:00 UTC [SEC Form 4] [Chairman, Co-CEO Portnoy David was granted 2,445 shares, increasing direct ownership by 0.13% to 847,629 units (SEC Form 4)](https://www.quantisnow.com/insight/chairman-co-ceo-portnoy-david-was-granted-2445-shares-increasing-direct-6292137)
- 2025-11-19 22:11 UTC [SEC Form 4] [Chairman, Co-CEO Portnoy David was granted 3,990 shares, increasing direct ownership by 0.47% to 846,540 units (SEC Form 4)](https://www.quantisnow.com/insight/chairman-co-ceo-portnoy-david-was-granted-3990-shares-increasing-direct-6287404)
- 2025-11-12 22:01 UTC [SEC Form 4] [Chairman, Co-CEO Portnoy David was granted 5,540 shares, increasing direct ownership by 0.66% to 842,550 units (SEC Form 4)](https://www.quantisnow.com/insight/chairman-co-ceo-portnoy-david-was-granted-5540-shares-increasing-direct-6275264)
- 2025-11-12 22:00 UTC [SEC Form 8-K] [Cryo-Cell International Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/cryo-cell-international-inc-filed-sec-form-8-k-other-events-6275239)
- 2025-11-04 22:26 UTC [SEC Form 4] [Chairman, Co-CEO Portnoy David was granted 9,666 shares, increasing direct ownership by 1% to 837,010 units (SEC Form 4)](https://www.quantisnow.com/insight/chairman-co-ceo-portnoy-david-was-granted-9666-shares-increasing-direct-6260200)
- 2025-10-23 21:00 UTC [SEC Form 8-K] [Cryo-Cell International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits](https://www.quantisnow.com/insight/cryo-cell-international-inc-filed-sec-form-8-k-entry-into-a-6243771)
- 2025-10-23 21:00 UTC [SEC Form 4] [SEC Form 4 filed by Director Mizrahi Daniel](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-mizrahi-daniel-6243764)
- 2025-10-23 21:00 UTC [SEC Form 4] [SEC Form 4 filed by Director Berger Harold D.](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-berger-harold-d-6243763)
- 2025-10-15 21:00 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Cryo-Cell International Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-cryo-cell-international-inc-6234394)
- 2025-10-15 21:00 UTC [Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2025 Financial Results](https://www.quantisnow.com/insight/cord-blood-banking-leader-cryo-cell-reports-fiscal-third-quarter-2025-6234375)
- 2025-09-26 21:00 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Cryo-Cell International Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-cryo-cell-international-inc-6213261)
- 2025-09-18 20:53 UTC [Insider Buy] [Chairman, Co-CEO Portnoy David bought $76,486 worth of shares (17,175 units at $4.45), increasing direct ownership by 2% to 827,344 units (SEC Form 4)](https://www.quantisnow.com/insight/chairman-co-ceo-portnoy-david-bought-76486-worth-of-shares-17175-6205891)
- 2025-09-10 21:22 UTC [Insider Buy] [Chairman, Co-CEO Portnoy David bought $189,986 worth of shares (42,900 units at $4.43), increasing direct ownership by 0.89% to 811,920 units (SEC Form 4)](https://www.quantisnow.com/insight/chairman-co-ceo-portnoy-david-bought-189986-worth-of-shares-42900-6196918)
- 2025-09-10 21:00 UTC [SEC Form 8-K] [Cryo-Cell International Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/cryo-cell-international-inc-filed-sec-form-8-k-other-events-6196841)
- 2025-09-02 21:18 UTC [SEC Form 4] [Chairman, Co-CEO Portnoy David disposed of 15,611 shares (SEC Form 4)](https://www.quantisnow.com/insight/chairman-co-ceo-portnoy-david-disposed-of-15611-shares-sec-form-6186352)
- 2025-08-27 21:23 UTC [Insider Buy] [Chairman, Co-CEO Portnoy David bought $176,198 worth of shares (39,179 units at $4.50) (SEC Form 4)](https://www.quantisnow.com/insight/chairman-co-ceo-portnoy-david-bought-176198-worth-of-shares-39179-6181266)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CCEL
- Earnings history: https://www.quantisnow.com/earnings/CCEL
- Dividend history: https://www.quantisnow.com/dividends/CCEL
- Insider transactions: https://www.quantisnow.com/insiders/CCEL
- Options chain: https://www.quantisnow.com/options/CCEL
- SEC 8-K filings only: https://www.quantisnow.com/company/CCEL/8-k
- RSS and alerts for CCEL: https://www.quantisnow.com/docs/rss-feeds.md